SLE Panel Review - EULAR 2023

RheumNow's SLE faculty convene to discuss highlight lupus abstracts from EULAR 2023, including:

Discussants:

Dr. Jack Cush, executive editor, RheumNow, Dallas, TX

Dr. Janet Pope, London, Canada

Dr. Bella Mehta, New York

Dr. Yuz Yusof, Leeds, UK

Topics include:

1. POS0170 - All cause mortality in SLE

2. OP0139 Upadacitinib (+/- BTK inhibitor) in SLE

3. Baricitinib in SLE Nephritis

4. POS0586 - Urinary CD163 in Lupus

5. OP0226 LLDAS & Remission in Lupus

6. OP0141 CAR-T Update in SLE

7. POS0120 Ianalumab in SLE

Dr. Jack Cush, executive editor, RheumNow, Dallas Dr. Janet Pope, London, Canada Dr. Bella Mehta, New York Dr. Yuz Yusof, Leeds, UK

Disclosures

The author has received compensation as an advisor or consultant on this subject

ADD THE FIRST COMMENT

If you are a health practitioner, you may Login/Register to comment.

Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.